 |
0 Diseases |  |
2 Trials |
|
2 Trials |  |
5 News |  |
- EPCAM-targeted CAR-T cells / Sinobioway
Enrollment open: Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer (clinicaltrials.gov) - Mar 23, 2017
P=N/A, N=19, Recruiting, Sponsor: Sinobioway Cell Therapy Co., Ltd.
Suspended --> Recruiting
- EPCAM-targeted CAR-T cells / Sinobioway
Phase classification, Trial primary completion date: EECLC: Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=25, Recruiting, Sponsor: Sinobioway Cell Therapy Co., Ltd.
Suspended --> Recruiting Phase classification: P1/2 --> P=N/A | Trial primary completion date: Oct 2016 --> Nov 2019
- EPCAM-targeted CAR-T cells / Sinobioway
Phase classification, Trial suspension, Trial primary completion date: Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=19, Suspended, Sponsor: Sinobioway Cell Therapy Co., Ltd.
Phase classification: P1/2 --> P=N/A | Trial primary completion date: Oct 2016 --> Nov 2019 Phase classification: P1/2 --> P=N/A | Recruiting --> Suspended | Trial primary completion date: Oct 2016 --> Nov 2019
- EPCAM-targeted CAR-T cells / Sinobioway
New P1/2 trial: EECLC: Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer (clinicaltrials.gov) - Apr 6, 2016
P1/2, N=25, Recruiting, Sponsor: Sinobioway Cell Therapy Co., Ltd.
- EPCAM-targeted CAR-T cells / Sinobioway
New P1/2 trial: Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer (clinicaltrials.gov) - Mar 31, 2016
P1/2, N=19, Recruiting, Sponsor: Sinobioway Cell Therapy Co., Ltd.